{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:23:21Z","timestamp":1791361401080,"version":"4.3.1"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230182-4\"><jats:title>Importance<\/jats:title><jats:p>Adults with psychotic disorders have high premature mortality, partly due to the high prevalence of smoking in this population. Yet recent data are lacking on tobacco product use among US adults with a history of psychosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-5\"><jats:title>Objective<\/jats:title><jats:p>To examine the sociodemographic characteristics and behavioral health status; types of tobacco products used; prevalence of use by age, sex, and race and ethnicity; and nicotine dependence severity and smoking cessation methods among community-dwelling adults with vs without psychosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cross-sectional study analyzed nationally representative, self-reported, cross-sectional data of adults (aged \u226518 years) who participated in the Wave 5 survey (conducted from December 2018 to November 2019) of the Population Assessment of Tobacco and Health (PATH) Study. Data analyses were conducted between September 2021 and October 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-7\"><jats:title>Exposure<\/jats:title><jats:p>PATH Study respondents were classified as having lifetime psychosis if they answered <jats:italic>yes<\/jats:italic> to whether they had ever received from a clinician (eg, physician, therapist, or other mental health professional) a diagnosis of schizophrenia, schizoaffective disorder, psychosis, or psychotic illness or episode.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Use of any and major types of tobacco products, severity of nicotine dependence, and cessation methods.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-9\"><jats:title>Results<\/jats:title><jats:p>Among the 29\u202f045 community-dwelling adults who participated in the PATH Study (weighted median [IQR] age, 30.0 [22.0-50.0] years; weighted percentage estimates: 14 976 females (51.5%); 16.0% Hispanic, 11.1% non-Hispanic Black, 65.0% non-Hispanic White, and 8.0% non-Hispanic other race and ethnicity [American Indian or Alaska Native, Asian, Native Hawaiian or other Pacific Islander, and more than 1 race]), 2.9% (95% CI, 2.62%-3.10%) reported receiving a lifetime psychosis diagnosis. Compared with those without psychosis, people with psychosis had a higher adjusted prevalence of past-month any tobacco use (41.3% vs 27.7%; adjusted risk ratio [RR], 1.49 [95% CI, 1.36-1.63]) as well as cigarette smoking, e-cigarette use, and other tobacco product use overall and in most examined subgroups; they also had a higher past-month prevalence of dual cigarette and e-cigarette use (13.5% vs 10.1%; <jats:italic>P<\/jats:italic>\u2009=\u2009.02), polycombustible tobacco use (12.1% vs 8.6%; <jats:italic>P<\/jats:italic>\u2009=\u2009.007), and polycombustible and noncombustible tobacco use (22.1% vs 12.4%; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Among adults with past-month cigarette use, those with vs without psychosis had a higher adjusted mean nicotine dependence scores overall (54.6 vs 49.5; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and within the 45-years-or-older (61.7 vs 54.9; <jats:italic>P<\/jats:italic>\u2009=\u2009.002), female (56.9 vs 49.8; <jats:italic>P<\/jats:italic>\u2009=\u2009.001), Hispanic (53.7 vs 40.0; <jats:italic>P<\/jats:italic>\u2009=\u2009.01), and Black (53.4 vs 46.0; <jats:italic>P<\/jats:italic>\u2009=\u2009.005) groups. They were also more likely to make a quit attempt (60.0% vs 54.1%; adjusted RR, 1.11 [95% CI, 1.01-1.21]) and use counseling, a quitline, or a support group for tobacco cessation (5.6% vs 2.5%; adjusted RR, 2.25 [95% CI, 1.21-3.30]).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230182-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this study, the high prevalence of tobacco use, polytobacco use, and making a quit attempt as well as the severity of nicotine dependence among community-dwelling adults with a history of psychosis highlighted the urgency for tailored tobacco cessation interventions for this population. Such strategies must be evidence-based and age, sex, and race and ethnicity appropriate.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.4995","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T15:06:40Z","timestamp":1680016000000},"page":"e234995","source":"Crossref","is-referenced-by-count":23,"title":["Tobacco Use, Nicotine Dependence, and Cessation Methods in US Adults With Psychosis"],"prefix":"10.1001","volume":"6","author":[{"given":"Beth","family":"Han","sequence":"first","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ther W.","family":"Aung","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"},{"name":"Kelly Government Solutions, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marushka L.","family":"Silveira","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland"},{"name":"Kelly Government Solutions, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Blanco","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson M.","family":"Compton","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"issue":"9","key":"zoi230182r1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S2215-0366(20)30261-3","article-title":"Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.","volume":"7","author":"Siskind","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"zoi230182r2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","article-title":"Prevention of psychosis: advances in detection, prognosis, and intervention.","volume":"77","author":"Fusar-Poli","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi230182r3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2215-0366(15)00152-2","article-title":"Does tobacco use cause psychosis? systematic review and meta-analysis.","volume":"2","author":"Gurillo","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"10037","key":"zoi230182r4","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"e2","key":"zoi230182r5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1136\/tobaccocontrol-2013-051466","article-title":"Smoking and mental illness in the U.S. population.","volume":"23","author":"Smith","year":"2014","journal-title":"Tob Control"},{"issue":"2","key":"zoi230182r6","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.4081\/hpr.2020.9237","article-title":"Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: a narrative review.","volume":"8","author":"Caponnetto","year":"2020","journal-title":"Health Psychol Res"},{"issue":"1","key":"zoi230182r7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.12788\/acp","article-title":"Characteristics of and reasons for electronic cigarette use among adult smokers with schizophrenia\/schizoaffective disorder.","volume":"34","author":"Wong","year":"2022","journal-title":"Ann Clin Psychiatry"},{"issue":"16","key":"zoi230182r8","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2022.4790","article-title":"Trends in prevalence of cigarette smoking among US adults with major depression or substance use disorders, 2006-2019.","volume":"327","author":"Han","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"zoi230182r9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1001\/jamapsychiatry.2015.0575","article-title":"Psychotic experiences in the general population: a cross-national analysis based on 31,261 respondents from 18 countries.","volume":"72","author":"McGrath","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"zoi230182r11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.18332\/tpc\/115030","article-title":"Characteristics of Chinese smokers with psychotic disorders and their predictors on smoking cessation in Hong Kong.","volume":"6","author":"Ho","year":"2020","journal-title":"Tob Prev Cessat"},{"issue":"1","key":"zoi230182r12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/070674370905400107","article-title":"Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients.","volume":"54","author":"Solty","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"6","key":"zoi230182r14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","article-title":"Sex differences in the risk of schizophrenia: evidence from meta-analysis.","volume":"60","author":"Aleman","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"zoi230182r15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/916198","article-title":"Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.","volume":"2012","author":"Ochoa","year":"2012","journal-title":"Schizophr Res Treatment"},{"issue":"4","key":"zoi230182r16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2105\/AJPH.2021.306631","article-title":"Structural racism and inequities in incidence, course of illness, and treatment of psychotic disorders among Black Americans.","volume":"112","author":"Misra","year":"2022","journal-title":"Am J Public Health"},{"issue":"10","key":"zoi230182r17","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00127-019-01737-3","article-title":"Differences in duration of untreated psychosis for racial and ethnic minority groups with first-episode psychosis: an updated systematic review and meta-analysis.","volume":"54","author":"Schoer","year":"2019","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"zoi230182r18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.schres.2019.10.002","article-title":"Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis.","volume":"215","author":"Ryan","year":"2020","journal-title":"Schizophr Res"},{"issue":"7","key":"zoi230182r21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1177\/070674370905400709","article-title":"Comorbidity of axis I and II mental disorders with schizophrenia and psychotic disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"54","author":"McMillan","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"1-3","key":"zoi230182r22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2013.10.018","article-title":"Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"151","author":"Davis","year":"2013","journal-title":"Schizophr Res"},{"issue":"9","key":"zoi230182r23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/da.20674","article-title":"The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"27","author":"Nepon","year":"2010","journal-title":"Depress Anxiety"},{"issue":"4","key":"zoi230182r24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/070674370605100407","article-title":"Self-reported diagnoses of schizophrenia and psychotic disorders may be valuable for monitoring and surveillance.","volume":"51","author":"Supina","year":"2006","journal-title":"Can J Psychiatry"},{"issue":"2-3","key":"zoi230182r25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0920-9964(97)85354-6","article-title":"The 100-year epidemiology of schizophrenia.","volume":"28","author":"Jablensky","year":"1997","journal-title":"Schizophr Res"},{"issue":"9426","key":"zoi230182r26","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(04)16458-1","article-title":"Schizophrenia.","volume":"363","author":"Mueser","year":"2004","journal-title":"Lancet"},{"key":"zoi230182r27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0264180100000904","article-title":"Schizophrenia: manifestations, incidence and course in different cultures\u2014a World Health Organization ten-country study.","volume":"20","author":"Jablensky","year":"1992","journal-title":"Psychol Med Monogr Suppl"},{"key":"zoi230182r28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10550490601006055","article-title":"Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime\/violence problems among adolescents and adults.","volume":"15","author":"Dennis","year":"2006","journal-title":"Am J Addict"},{"key":"zoi230182r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108134","article-title":"Predictive validity of the adult tobacco dependence index: findings from waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study.","volume":"214","author":"Strong","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi230182r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106787","article-title":"A longitudinal assessment of nicotine dependence, mental health, and attempts to quit smoking: evidence from waves 1-4 of the Population Assessment of Tobacco and Health (PATH) study.","volume":"115","author":"Snell","year":"2021","journal-title":"Addict Behav"},{"key":"zoi230182r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107715","article-title":"Adolescent menthol cigarette use and risk of nicotine dependence: findings from the national Population Assessment on Tobacco and Health (PATH) study.","volume":"206","author":"Cwalina","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi230182r32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15288\/jsad.2020.81.595","article-title":"A longitudinal analysis of nicotine dependence and transitions from dual use of cigarettes and electronic cigarettes: evidence from waves 1-3 of the PATH study.","volume":"81","author":"Snell","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"key":"zoi230182r33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1017\/S0033291720000136","article-title":"Cigarette smoking as a risk factor for schizophrenia or all non-affective psychoses.","volume":"51","author":"King","year":"2021","journal-title":"Psychol Med"},{"key":"zoi230182r34","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319859969","article-title":"The relationship between nicotine and psychosis.","author":"Quigley","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"key":"zoi230182r35","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ntr\/nty050","article-title":"Polytobacco use and nicotine dependence symptoms among US adults, 2012-2014.","volume":"20","author":"Sung","year":"2018","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"zoi230182r36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.drugalcdep.2005.04.002","article-title":"Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls.","volume":"80","author":"Tidey","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"zoi230182r37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajp.2019.05.002","article-title":"Tobacco smoking and nicotine dependence in first episode and established psychosis.","volume":"43","author":"Lally","year":"2019","journal-title":"Asian J Psychiatr"},{"issue":"8","key":"zoi230182r38","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/jcm10081619","article-title":"Smoking is related to reduced motivation, but not global cognition, in the first two years of treatment for first episode psychosis.","volume":"10","author":"Schermitzler","year":"2021","journal-title":"J Clin Med"},{"key":"zoi230182r39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.schres.2021.08.006","article-title":"Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: a longitudinal study.","volume":"236","author":"van der Heijden","year":"2021","journal-title":"Schizophr Res"},{"key":"zoi230182r40","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7698030","article-title":"Cigarette smoking and schizophrenia: etiology, clinical, pharmacological, and treatment implications.","volume":"2021","author":"Ding","year":"2021","journal-title":"Schizophr Res Treatment"},{"issue":"4","key":"zoi230182r41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/schbul\/sbp152","article-title":"Cigarette smoking and mortality risk in people with schizophrenia.","volume":"37","author":"Kelly","year":"2011","journal-title":"Schizophr Bull"},{"issue":"11","key":"zoi230182r42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1176\/appi.ajp.2018.18010069","article-title":"Association between smoking behavior and cognitive functioning in patients with psychosis, siblings, and healthy control subjects: results from a prospective 6-year follow-up study.","volume":"175","author":"Vermeulen","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"4","key":"zoi230182r43","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3109\/00048670903489841","article-title":"Cigarette smoking and psychosis: naturalistic follow up 4 years after an intervention trial.","volume":"44","author":"Baker","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"zoi230182r44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fpsyt.2018.00565","article-title":"A systematic review of psychosocial barriers and facilitators to smoking cessation in people living with schizophrenia.","volume":"9","author":"Lum","year":"2018","journal-title":"Front Psychiatry"},{"issue":"11","key":"zoi230182r45","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1176\/appi.ps.201800067","article-title":"Racial-ethnic disparities in first-episode psychosis treatment outcomes from the RAISE-ETP study.","volume":"69","author":"Oluwoye","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"6","key":"zoi230182r46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amepre.2015.11.006","article-title":"The quit experience and concerns of smokers with psychiatric illness.","volume":"50","author":"Tulloch","year":"2016","journal-title":"Am J Prev Med"},{"issue":"10","key":"zoi230182r47","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay9763","article-title":"Current advances in research in treatment and recovery: nicotine addiction.","volume":"5","author":"Prochaska","year":"2019","journal-title":"Sci Adv"},{"issue":"11","key":"zoi230182r48","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1176\/appi.ajp.2020.19090900","article-title":"Nicotine use and DSM-IV nicotine dependence in the United States, 2001\u20132002 and 2012\u20132013.","volume":"177","author":"Grant","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"3","key":"zoi230182r49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jamapsychiatry.2020.3995","article-title":"Association between race\/ethnicity and disparities in health care use before first-episode psychosis among privately insured young patients.","volume":"78","author":"Heun-Johnson","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi230182r50","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1176\/appi.ajp.157.11.1727","article-title":"Delayed detection of psychosis: causes, consequences, and effect on public health.","volume":"157","author":"Lieberman","year":"2000","journal-title":"Am J Psychiatry"},{"key":"zoi230182r10","volume-title":"Smoking Cessation: A Report of the Surgeon General","author":"US Department of Health and Human Services","year":"2020"},{"key":"zoi230182r13","author":"Han","year":"2020"},{"key":"zoi230182r19","unstructured":"National Addiction & HIV Data Archive Program. Population Assessment of Tobacco and Health (PATH) study series. Accessed June 10, 2022. https:\/\/www.icpsr.umich.edu\/web\/NAHDAP\/series\/606?"},{"key":"zoi230182r20","unstructured":"National Institute on Alcohol Abuse and Alcoholism. National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Accessed January 2, 2023. https:\/\/www.niaaa.nih.gov\/research\/nesarc-iii"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2802812\/han_2023_oi_230182_1678995971.0484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T15:06:47Z","timestamp":1680016007000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2802812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.4995","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}